These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3554597)

  • 1. [Evaluation of the activity of vindeburnol by spectral analysis of human EEG].
    Patat A; Klein MJ
    Therapie; 1986; 41(4):305-10. PubMed ID: 3554597
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationship of vindeburnol based on spectral analysis of posturographic recordings.
    Patat A; Le Go A; Foulhoux P
    Eur J Clin Pharmacol; 1985; 29(4):455-9. PubMed ID: 3912189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of spectrum analysis of equilibration recordings (posturography) in clinical pharmacology of vindeburnol].
    Patat A; Foulhoux P; Venet R; Memin Y
    Therapie; 1984; 39(6):639-45. PubMed ID: 6531737
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute i.v. vincamine teprosilate administration: quantified investigation in elderly subjects.
    Moglia A; Alfonsi E; Zandrini C; Pistarini C; Arrigo A
    Int J Clin Pharmacol Res; 1984; 4(4):303-6. PubMed ID: 6500777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia.
    Barzaghi F; Dragonetti M; Formento ML; Boissier JR
    Arzneimittelforschung; 1985; 35(2):472-7. PubMed ID: 4039569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincamine TPS activity on glycoconjugate metabolism of the brain: effect on lysosomal enzymes.
    Federico A; D'Amore I
    Int J Clin Pharmacol Res; 1984; 4(4):277-9. PubMed ID: 6500774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eburnamine derivatives and the brain.
    Vas A; Gulyás B
    Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease.
    Martucci N; Manna V; Agnoli A
    Int J Clin Pharmacol Res; 1984; 4(4):291-302. PubMed ID: 6500776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
    G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of vincamine on EEG sleep patterns in man: a pilot study.
    Albizzati MG; Bassi S; Binda G; Passerini D
    Curr Med Res Opin; 1980; 6(10):653-7. PubMed ID: 7428402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
    Mazzola C; Della Torre F; Izzo M; Colombo Pirola L
    Clin Ter; 1979 Dec; 91(5):485-503. PubMed ID: 397034
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interaction of vincamine on various effects of amphetamine at the central level].
    Sardi B; Pesce E; Piacenza G
    Farmaco Prat; 1978 Aug; 33(8):351-7. PubMed ID: 748060
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
    Petruzzi E; Bucalossi A
    Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
    Mikus P; Polák O; Ochsenreither AM
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):39-49. PubMed ID: 4602891
    [No Abstract]   [Full Text] [Related]  

  • 19. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
    Maeda T
    Nihon Rinsho; 1985 Feb; 43(2):389-91. PubMed ID: 3889412
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe hypocapnia applied to study the effect of vincamine on cerebral circulation.
    Palacios L; Roca J; Balasch J
    Arch Farmacol Toxicol; 1978 Aug; 4(2):261-4. PubMed ID: 727839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.